New nanoparticles shrink tumors in mice
Particles that shut off cancer genes could also allow researchers to screen potential drug targets more rapidly.
Particles that shut off cancer genes could also allow researchers to screen potential drug targets more rapidly.
Findings answer puzzling question of how cells know when to progress through the cell cycle.
New MIT study shows that staggered delivery of cancer drugs is far more effective than administering them at the same time.
Institutions, research teams, non-profit organizations join forces in novel approaches targeting pancreatic cancer, glioblastoma.
MIT cancer biologists determine how platelets in the bloodstream help cancer cells form new tumors.
Cancer biologists identify a driving force behind the spread of an aggressive type of lung cancer.
The gene they found can double yeast lifespan when turned on late in life.
Combining an ancient principle with new technology, MIT researchers have devised a way to answer that question.
MIT-designed nanoparticles communicate with each other inside the body to target tumors more efficiently.'
MIT biologists pinpoint a genetic change that helps tumors move to other parts of the body.
Researchers gather to discuss the state of their field and the potential for new treatments.
MIT celebrates the official opening of the institute's new building.
Team identifies potential drugs that enhance stress caused by too many chromosomes.